Scinai Immunotherapeutics Ltd.

Scinai Immunotherapeutics Ltd.verified

SCNI

Price:

$1.0779

Market Cap:

$1.42M

Scinai Immunotherapeutics Ltd., a development stage biopharmaceutical company, focuses on developing, manufacturing, and commercializing products for the prevention and treatment of infectious and autoimmune diseases, and other illnesses in Israel. It has licensing and collaboration agreement with Max Planck Society and University Medical Center Göttingen for the development and commercialization of COVID-19 nanosized antibody (NanoAb); and development and commercialization of NanoAbs for various other disease indications. The company was formerly known as BiondVax Pharmaceuticals Ltd. and changed its name to Scinai Immunotherapeutics Ltd. in September 2023. Scinai Immunotherapeutics Ltd. wa...[Read more]

Industry

Biotechnology

IPO Date

2015-05-11

Stock Exchange

NASDAQ

Ticker

SCNI

The Enterprise Value as of December 2025 (TTM) for Scinai Immunotherapeutics Ltd. (SCNI) is 2.78M

According to Scinai Immunotherapeutics Ltd.’s latest financial reports and current stock price. The company's current Enterprise Value is 2.78M. This represents a change of -14.79% compared to the average of 3.27M of the last 4 quarters.

Scinai Immunotherapeutics Ltd. (SCNI) Historical Enterprise Value (quarterly & annually)

How has SCNI Enterprise Value performed in the past?

The mean historical Enterprise Value of Scinai Immunotherapeutics Ltd. over the last ten years is 26.40M. The current 2.78M Enterprise Value has changed 954.71% with respect to the historical average. Over the past ten years (40 quarters), SCNI's Enterprise Value was at its highest in in the September 2020 quarter at 552.64M. The Enterprise Value was at its lowest in in the December 2024 quarter at 1.44M.

Quarterly (TTM)
Annual

Average

26.40M

Median

15.53M

Minimum

1.86M

Maximum

92.90M

Scinai Immunotherapeutics Ltd. (SCNI) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Scinai Immunotherapeutics Ltd. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 399.69%

Maximum Annual Enterprise Value = 92.90M

Minimum Annual Increase = -84.33%

Minimum Annual Enterprise Value = 1.86M

Quarterly (TTM)
Annual
YearEnterprise ValueChange
20242.82M-84.33%
202318.02M38.08%
202213.05M-63.47%
202135.72M-27.26%
202049.10M-47.14%
201992.90M157.22%
201836.11M399.69%
20177.23M-0.14%
20167.24M289.87%
20151.86M-57.01%

Scinai Immunotherapeutics Ltd. (SCNI) Average Enterprise Value

How has SCNI Enterprise Value performed in the past?

The current Enterprise Value of Scinai Immunotherapeutics Ltd. (SCNI) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

11.30M

5-year avg

23.74M

10-year avg

26.40M

Scinai Immunotherapeutics Ltd. (SCNI) Enterprise Value vs. Peers

How is SCNI’s Enterprise Value compared to its peers?

Scinai Immunotherapeutics Ltd.’s Enterprise Value is greater than Onconetix, Inc. (1.01M), greater than SciSparc Ltd. (-577828.00), greater than Azitra, Inc. (-898448849.00), greater than Indaptus Therapeutics, Inc. (-2307685.00), greater than Silexion Therapeutics Ltd. (1.97M), greater than Salarius Pharmaceuticals, Inc. (523.73K), greater than Jasper Therapeutics, Inc. (-7694060.00), greater than Revelation Biosciences, Inc. (-6780799.00), greater than Psyence Biomedical Ltd. (-4843859.00), greater than Enveric Biosciences, Inc. (714.14K),

Build a custom stock screener for Scinai Immunotherapeutics Ltd. (SCNI) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Scinai Immunotherapeutics Ltd. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Scinai Immunotherapeutics Ltd. (SCNI) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Scinai Immunotherapeutics Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is Scinai Immunotherapeutics Ltd.'s Enterprise Value?

What is the highest Enterprise Value for Scinai Immunotherapeutics Ltd. (SCNI)?

What is the 3-year average Enterprise Value for Scinai Immunotherapeutics Ltd. (SCNI)?

What is the 5-year average Enterprise Value for Scinai Immunotherapeutics Ltd. (SCNI)?

How does the current Enterprise Value for Scinai Immunotherapeutics Ltd. (SCNI) compare to its historical average?